- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens showcases 3T, 1.5T scanners
Siemens Healthcare is focusing on its 3T Verio and 1.5T Essenza at the ISMRM meeting. Both were unveiled last year at the RSNA meeting.
Siemens Healthcare is focusing on its 3T Verio and 1.5T Essenza at the ISMRM meeting. Both were unveiled last year at the RSNA meeting.
Twenty of the wide-bore 3T scanners are operating, even though Verio began shipping only last month. Essenza sites are also running in Europe, Asia, and the U.S.
Verio's 70-cm bore offers more patient-friendly positioning, according to the company, while its off-center scanning with dedicated coils shortens the workflow and improves data acquisition. Its ultracompact magnet, measuring 173 cm long, has the footprint of a 1.5T MRI system. All told, it weighs a relatively light six tons.
The scanner comes equipped with the company's own breed of coil technology, based on Tim (total imaging matrix) technology, which supports up to 102 integrated matrix coil elements and up to 32 radiofrequency channels.
Priced under a million dollars, Essenza's appeal is as an inexpensive 1.5T workhorse. The company is targeting budget-strapped first-time buyers who otherwise might purchase refurbished or low-end technology, as well as institutions that already have MR but want to increase capacity and decrease waiting times for patients.
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
January 20th 2025In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
